Eagle Pharmaceuticals
EGRX
#10068
Rank
C$17.53 M
Marketcap
$1.35
Share price
-5.50%
Change (1 day)
-80.93%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): C$47.96 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are C$0.25 Billion. In 2022 the company made an earning of C$94.31 Million, an increase over its 2021 earnings that were of -C$4.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) C$47.96 M-49.14%
2022 C$94.31 M-2361.45%
2021 -C$4.18 Million-111.53%
2020 C$36.15 M2.31%
2019 C$35.34 M-32.89%
2018 C$52.65 M-50.35%
2017 C$0.10 B38.63%
2016 C$76.5 M1966.43%
2015 C$3.7 M-111.46%
2014 -C$32.32 Million282.82%
2013 -C$8.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$24.97 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.29 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$19.52 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.41 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$6.59 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.15 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$12 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA